These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 31765763)
21. Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB. Xie T; Luo G; Zhang Y; Wang X; Wang X; Wu M; Li G Clin Exp Allergy; 2015 Dec; 45(12):1812-22. PubMed ID: 26245530 [TBL] [Abstract][Full Text] [Related]
22. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease. Li J; Zhao P; Li Y; Tian Y; Wang Y Sci Rep; 2015 Oct; 5():15290. PubMed ID: 26469778 [TBL] [Abstract][Full Text] [Related]
23. Revealing active ingredients, potential targets, and action mechanism of Ermiao fang for treating endometritis based on network pharmacology strategy. Zhang C; Su T; Yu D; Wang F; Yue C; Wang HQ J Ethnopharmacol; 2020 Oct; 260():113051. PubMed ID: 32505843 [TBL] [Abstract][Full Text] [Related]
24. Tanreqing injection inhibits influenza virus replication by promoting the fusion of autophagosomes with lysosomes: An integrated pharmacological study. Guo R; Liu H; Su R; Mao Q; Zhao M; Zhang H; Mu J; Zhao N; Wang Y; Hao Y J Ethnopharmacol; 2024 Sep; 331():118159. PubMed ID: 38677572 [TBL] [Abstract][Full Text] [Related]
25. Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats. Liu Z; Geng W; Jiang C; Zhao S; Liu Y; Zhang Y; Qin S; Li C; Zhang X; Si Y Exp Biol Med (Maywood); 2017 Sep; 242(15):1534-1541. PubMed ID: 28795606 [TBL] [Abstract][Full Text] [Related]
26. The pathophysiological mechanisms underlying mucus hypersecretion induced by cold temperatures in cigarette smoke-exposed rats. Li MC; Yang G; Zhou XD; Tselluyko S; Perelman JM Int J Mol Med; 2014 Jan; 33(1):83-90. PubMed ID: 24154796 [TBL] [Abstract][Full Text] [Related]
27. [A study of the mechanism of Qingre Huatan therapy in treatment of acute exacerbation of chronic obstructive pulmonary disease by improving airway inflammation and mucus hypersecretion]. Li W; Mao B; Wang G; Wang L; Chang J; Zhang Y; Wan MH; Guo J Zhong Xi Yi Jie He Xue Bao; 2008 Aug; 6(8):799-805. PubMed ID: 18664347 [TBL] [Abstract][Full Text] [Related]
28. Carbocisteine inhibits the expression of Muc5b in COPD mouse model. Song Y; Wang W; Xie Y; Xiang B; Huang X; Guan W; Zheng J Drug Des Devel Ther; 2019; 13():3259-3268. PubMed ID: 31571828 [TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of Jianpiyifei II granules in the treatment of chronic obstructive pulmonary disease: Network pharmacology analysis, molecular docking, and experimental assessment. Xie D; Quan J; Yu X; Liang Z; Chen Y; Wu L; Lin L; Fan L Phytomedicine; 2024 Apr; 126():155273. PubMed ID: 38342020 [TBL] [Abstract][Full Text] [Related]
30. Network pharmacology study to reveal active compounds of Qinggan Yin formula against pulmonary inflammation by inhibiting MAPK activation. Jin Z; Sheng H; Wang S; Wang Y; Cheng Y J Ethnopharmacol; 2022 Oct; 296():115513. PubMed ID: 35779819 [TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of mucus hypersecretion in airway of rats induced by synergies between cold air and cigarette smoke inhalation and intervention effects of drugs]. Li MC; Perelman JM; Kolosov VP; Zhou XD Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(32):2283-7. PubMed ID: 23158492 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 neutralizing antibody attenuates the hypersecretion of airway mucus via inducing the nuclear translocation of Nrf2 in chronic obstructive pulmonary disease. Wei YY; Zhang DW; Ye JJ; Lan QX; Ji S; Sun L; Li F; Fei GH Biomed Pharmacother; 2022 Aug; 152():113244. PubMed ID: 35687911 [TBL] [Abstract][Full Text] [Related]
33. Active ingredients targeting Nrf2 in the Mongolian medicine Qiwei Putao powder: Systematic pharmacological prediction and validation for chronic obstructive pulmonary disease treatment. Deng YX; Zhong J; Liu ZJ; Wang XQ; Zhang B J Ethnopharmacol; 2021 Jan; 265():113385. PubMed ID: 32920133 [TBL] [Abstract][Full Text] [Related]
34. The Potential Role and Regulatory Mechanisms of MUC5AC in Chronic Obstructive Pulmonary Disease. Li J; Ye Z Molecules; 2020 Sep; 25(19):. PubMed ID: 32992527 [TBL] [Abstract][Full Text] [Related]
35. Network Pharmacology Analysis of the Mechanisms of Compound Herba Sarcandrae (Fufang Zhongjiefeng) Aerosol in Chronic Pharyngitis Treatment. Zhang Y; Yuan T; Li Y; Wu N; Dai X Drug Des Devel Ther; 2021; 15():2783-2803. PubMed ID: 34234411 [TBL] [Abstract][Full Text] [Related]
36. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling. Xu K; Ma J; Lu R; Shao X; Zhao Y; Cui L; Qiu Z; Tian Y; Li J Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 36799253 [TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts. Seibel J; Kryshen K; Pongrácz JE; Lehner MD Pulm Pharmacol Ther; 2018 Aug; 51():10-17. PubMed ID: 29698781 [TBL] [Abstract][Full Text] [Related]
38. Tanreqing injection protects against bleomycin-induced pulmonary fibrosis via inhibiting STING-mediated endoplasmic reticulum stress signaling pathway. Deng J; He Y; Sun G; Yang H; Wang L; Tao X; Chen W J Ethnopharmacol; 2023 Apr; 305():116071. PubMed ID: 36584920 [TBL] [Abstract][Full Text] [Related]
39. The potential interaction of MARCKS-related peptide and diltiazem on acrolein-induced airway mucus hypersecretion in rats. Chen P; Deng Z; Wang T; Chen L; Li J; Feng Y; Zhang S; Nin Y; Liu D; Chen Y; Ou X; Wen F Int Immunopharmacol; 2013 Nov; 17(3):625-32. PubMed ID: 24012931 [TBL] [Abstract][Full Text] [Related]
40. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. Lai H; Rogers DF J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]